Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Feb 01, 2023. (Total: 4188 publications since 2011)
   dataset
Filtered By:
Next
Records 1-30 (of 33 Records)
Query Trace: all>>Scott D Grosse[CDC Author]
Correspondence on "Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions" by Lavelle et al.
Scott D Grosse, and James M Gudgeon
Genetics in medicine : official journal of the American College of Medical Genetics 2022
Cost or price of sequencing? Implications for economic evaluations in genomic medicine.
Scott D Grosse, and James M Gudgeon
Genetics in medicine : official journal of the American College of Medical Genetics 2021
Health and economic outcomes of newborn screening for infantile-onset Pompe disease.
John S Richardson, Alex R Kemper, Scott D Grosse, Wendy K K Lam, Angela M Rose, Ayesha Ahmad, Achamyeleh Gebremariam, and Lisa A Prosser
Genetics in medicine : official journal of the American College of Medical Genetics 2020 Dec
Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017.
Marci K Sontag, Careema Yusuf, Scott D Grosse, Sari Edelman, Joshua I Miller, Sarah McKasson, Yvonne Kellar-Guenther, Marcus Gaffney, Cynthia F Hinton, Carla Cuthbert, Sikha Singh, Jelili Ojodu, and Stuart K Shapira
MMWR. Morbidity and mortality weekly report 2020 Sep 69(36) 1265-1268
Ensuring the Life-Span Benefits of Newborn Screening.
Alex R Kemper, Coleen A Boyle, Jeffrey P Brosco, and Scott D Grosse
Pediatrics 2019 Nov
Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.
Lisa A Prosser, K K Lam, Scott D Grosse, Mia Casale, and Alex R Kemper
MDM policy & practice 3(1)
Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?
Scott D Grosse, and Lauge Farnaes
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Aug
Is universal tumor testing for Lynch syndrome cost-effective? It depends!
Scott D Grosse
Genetics in medicine : official journal of the American College of Medical Genetics 2018 May
Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.
Lisa B Feng, Scott D Grosse, Ridgely Fisk Green, Aliza K Fink, and Gregory S Sawicki
Health affairs (Project Hope) 2018 May 37(5) 773-779
In Reference to: "Cost and Utility of Thrombophilia Testing".
Brygida Berse, Julie A Lynch, Scott Bowen, and Scott D Grosse
Journal of hospital medicine 2017 Sep 12(9) 783
Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes.
Scott D Grosse, Lyle C Gurrin, Nadine A Bertalli, and Katrina J Allen
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Apr 20(4) 383-389
Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.
Scott D Grosse, Wendy K K Lam, Lisa D Wiggins, and Alex R Kemper
Genetics in medicine : official journal of the American College of Medical Genetics 2017 19(9) 975-982
The need for a next-generation public health response to rare diseases.
Rodolfo Valdez, Scott D Grosse, and Muin J Khoury
Genetics in medicine : official journal of the American College of Medical Genetics 2016 Oct
Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing.
Scott D Grosse, and Muin J Khoury
Genetics in medicine : official journal of the American College of Medical Genetics 2016 18(10) 963-5
Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation.
Alex R Kemper, Jeffrey Brosco, Anne Marie Comeau, Nancy S Green, Scott D Grosse, Elizabeth Jones, Jennifer M Kwon, Wendy K K Lam, Jelili Ojodu, Lisa A Prosser, and Susan Tanksley
Genetics in medicine : official journal of the American College of Medical Genetics 2017 19(1) 121-126
Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
Yao Ding, John D Thompson, Lisa Kobrynski, Jelili Ojodu, Guisou Zarbalian, and Scott D Grosse
The Journal of pediatrics 2016 Feb
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.
Maria D Karaceper, Pranesh Chakraborty, Doug Coyle, Kumanan Wilson, Jonathan B Kronick, Steven Hawken, Christine Davies, Marni Brownell, Linda Dodds, Annette Feigenbaum, Deshayne B Fell, Scott D Grosse, Astrid Guttmann, Anne-Marie Laberge, Aizeddin Mhanni, Fiona A Miller, John J Mitchell, Meranda Nakhla, Chitra Prasad, Cheryl Rockman-Greenberg, Rebecca Sparkes, Brenda J Wilson, Beth K Potter, and
Orphanet journal of rare diseases 2016 Feb 1112
Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
Scott D Grosse
Healthcare (Basel, Switzerland) 2015 3(4) 1133-57
Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium.
Frédéric B Piel, Thomas V Adamkiewicz, Djesika Amendah, Thomas N Williams, Sunetra Gupta, and Scott D Grosse
Genetics in medicine : official journal of the American College of Medical Genetics 2015 Dec
When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives.
Scott D Grosse
Healthcare (Basel, Switzerland) 2015 3(4) 860-78
The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates.
Scott D Grosse, Glenn E Palomaki, Mercy Mvundura, and Heather Hampel
Genet. Med. 2015 Jun 17(6) 510-1
Universal state newborn screening programs can reduce health disparities.
Jeffrey P Brosco, Scott D Grosse, and Lainie Friedman Ross
JAMA Pediatr 2015 Jan 169(1) 7-8
Mortality of New York children with sickle cell disease identified through newborn screening.
Ying Wang, Gang Liu, Michele Caggana, Joseph Kennedy, Regina Zimmerman, Suzette O Oyeku, Ellen M Werner, Althea M Grant, Nancy S Green, and Scott D Grosse
Genet. Med. 2015 Jun 17(6) 452-9
Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.
Scott D Grosse
Genet. Med. 2014 Mar 16(3) 225-7
Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?
Wolf H Rogowski, Scott D Grosse, Jörg Schmidtke, and Georg Marckmann
Eur. J. Hum. Genet. 2014 Jan 22(1) 25-31
The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.
Scott D Grosse, Sheree L Boulet, Althea M Grant, Mary M Hulihan, and Marie E Faughnan
Genet. Med. 2014 Jan 16(1) 33-9
Modeling uncertain outcomes of genetic testing: factor V Leiden mutation and pregnant women.
Scott D Grosse, and Aaron B Caughey
Genet. Med. 2013 May 15(5) 335-7
Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity.
Ying Wang, Joseph Kennedy, Michele Caggana, Regina Zimmerman, Sanil Thomas, John Berninger, Katharine Harris, Nancy S Green, Suzette Oyeku, Mary Hulihan, Althea M Grant, and Scott D Grosse
Genetics in medicine : official journal of the American College of Medical Genetics 2013 Mar 15(3) 222-8
Decision analysis, economic evaluation, and newborn screening: challenges and opportunities.
Lisa A Prosser, Scott D Grosse, Alex R Kemper, Beth A Tarini, and James M Perrin
Genet. Med. 2012 Apr 5.
Iron overload: what is the role of public health?
Mary M Hulihan, Cindy A Sayers, Scott D Grosse, Cheryl Garrison, and Althea M Grant
Am J Prev Med 2011 Dec 41(6 Suppl 4) S422-7
TOP